Last updated: January 4, 2023
Sponsor: Shahid Beheshti University
Overall Status: Completed
Phase
N/A
Condition
Open Heart Surgery
Cardiac Surgery
Heart Transplantation
Treatment
N/AClinical Study ID
NCT05402826
30285
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients who are candidates for open heart surgery (coronary artery bypass grafting)
Exclusion
Exclusion Criteria:
- Frequent use of multivitamin, zinc, vitamin E, vitamin C, omega-3 supplements over thepast month
- Active cancer, chronic rheumatic disease, ESRD, liver cirrhosis, severe infection (WBC> 12000 mm3) before surgery
- Continued use of corticosteroids or NSAIDs for two weeks prior to admission (exceptA.S.A)
Study Design
Total Participants: 78
Study Start date:
June 06, 2022
Estimated Completion Date:
January 03, 2023
Study Description
Connect with a study center
Shafa Hospital, Kerman University of Medical Sciences
Kerman,
Iran, Islamic Republic ofSite Not Available
Shahid Beheshti University of Medical Sciences
Tehran,
Iran, Islamic Republic ofSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.